These Tech Stocks Will Make Me Rich

Welcome to week 54 of my stock-picking throwdown with Mr. Market. 

Let's get right to the numbers:

Company

Starting Price*

Recent Price

Total Return

Akamai

$22.23

$17.96

(19.2%)

Harris & Harris

$6.22

$6.01

(3.4%)

IBM

$126.39**

$118.95

(5.9%)

Oracle

$22.64**

$21.94

(3.1%)

Taiwan Semiconductor

$9.81**

$10.44

6.4%

AVERAGE RETURN

--

--

(5.04%)

S&P 500 SPDR

$123.67**

$100.99

(18.34%)

DIFFERENCE

--

--

13.30

Source: Yahoo! Finance.*Tracking began on Aug. 7, 2008.**Adjusted for dividends and other returns of capital.

Week two of the second year of this contest was a bad one for my tech portfolio, thanks mostly to a reversal at volatile tiny tech investor Harris & Harris. Investors sold in an up-and-down week.

Uncertainty still reigns. Not only does the health-care debate raise questions, it has Fools taking sides. Brian Orelli believes Congress is using its subpoena power to orchestrate a witch hunt against the likes of WellPoint (NYSE: WLP  ) and UnitedHealth Group (NYSE: UNH  ) . Nathan Alderman says a public plan could help spur much-needed competition. Read both arguments and decide for yourself.

And then, when you're done, try reading a bank balance sheet. How Wells Fargo (NYSE: WFC  ) and KeyCorp (NYSE: KEY  ) value the loans on their books can be very different from the actual fair value of what they hold. Shocking.

So far, no one is demanding banks fix accounting discrepancies and lend transparency to their books. But that day may be coming. New York's Attorney General, Andrew Cuomo, is taking on Wall Street in a manner reminiscent of his predecessor, Eliot Spitzer.

Cuomo's latest target: Charles Schwab (Nasdaq: SCHW  ) . He accuses the broker of misrepresenting the risks of buying and holding auction-rate securities, a charge that Schwab founder and CEO Chuck Schwab disputed in a recent editorial in the pages of The Wall Street Journal. Who's right? That's for a court to decide. But whomever you side with, one thing seems clear: reformers aren't done with the financial industry.

The week in tech
Silicon Valley's best didn't exactly come out swinging this week, either. Venture capitalists named their favorite IPO and acquisition candidates in a poll conducted by Reuters, and neither Twitter nor Facebook made the list.

Sirius XM (Nasdaq: SIRI  ) , meanwhile, is aiming to boost revenue via another iPhone hook-up. The "SkyDock" proposes to transform any iPod or iPhone into a fully functional satellite radio with access to all of Sirius XM's content. Color me interested -- I don't drive enough for a Sirius receiver, but a portable option could make sense, if done in a manner that befits Apple's (Nasdaq: AAPL  ) style and panache.

Plenty of others are copying the iEmpire's formula. New research from NPD Group shows that makers of plain-vanilla feature phones are now piling on the chocolate. Roughly 26% of all new handsets -- not just smartphones -- shipped with a touchscreen, and 20% had support for Wi-Fi.

So be it. History says that tech markets are prone to disruption, and that tech investors do best when they're patient, as David Gardner has been. He produced a decade of 20% returns in the real-money Rule Breaker portfolio. Tom Gardner's "simpleton portfolio" was also a 10-year winner. I believe that, with these five tech stocks, I will achieve similar success.

Checkup time!
Now let's move on to the rest of today's update. Oracle finally received the blessing of the Department of Justice to move forward with its $7.4 billion acquisition of Sun Microsystems. Expect the database king to structure itself for more consultative sales pitches that combine hardware, applications, and middleware. Or, in simpler terms: Get ready for Oracle to look a lot like IBM.

There's your checkup. See you back here next week for more tech stock talk.

Get your clicks with more techie Foolishness:

Akamai, and Harris & Harris are Motley Fool Rule Breakers recommendations. UnitedHealth and WellPoint are Motley Fool Inside Value picks. Apple, Charles Schwab, and UnitedHealth are Motley Fool Stock Advisor selections. The Fool owns shares of UnitedHealth. Try any of our Foolish newsletter services free for 30 days.

Fool contributor Tim Beyers had stock and options positions in Apple and stock positions in Akamai, Harris & Harris, IBM, Oracle, and Taiwan Semiconductor at the time of publication. Check out his portfolio holdings and Foolish writings, or connect with him on Twitter as @milehighfool.

The Motley Fool is also on Twitter as @TheMotleyFool. Its disclosure policy is tech-tastic.


Read/Post Comments (2) | Recommend This Article (22)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 969311, ~/Articles/ArticleHandler.aspx, 8/27/2014 11:26:38 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement